Modulation of CCR2 in rheumatoid arthritis: A double‐blind, randomized, placebo‐controlled clinical trial

2008 ◽  
Vol 58 (7) ◽  
pp. 1931-1939 ◽  
Author(s):  
Clarissa E. Vergunst ◽  
Daniëlle M. Gerlag ◽  
Luba Lopatinskaya ◽  
L. Klareskog ◽  
M. D. Smith ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Clinical Trial ◽  
Controlled Clinical Trial ◽  
Double Blind

A Controlled Clinical Trial of a New Anti-Inflammatory Drug, Diftalone, in Rheumatoid Arthritis

1974 ◽  
Vol 2 (5) ◽  
pp. 338-346 ◽  
Author(s):  
Valentin Stroescu ◽  
Carmen Georgescu ◽  
Radu Voiosu
Keyword(s):  
Rheumatoid Arthritis ◽  
Clinical Trial ◽  
Randomized Trial ◽  
Term Treatment ◽  
Controlled Clinical Trial ◽  
Double Blind ◽  
Inflammatory Drug ◽  
Long Term Treatment ◽  
Anti Inflammatory

In a double-blind, randomized trial on thirty-two patients affected by classical or definite rheumatoid arthritis, we have tried the effectiveness and safety of 500 mg/day oral diftalone versus 75 mg/day oral indomethacin for a period of six to twelve months treatment. Diftalone proved to be an effective and well tolerated anti-inflammatory drug in long-term treatment of rheumatoid arthritis. Its activity and safety is at least comparable to that achieved by the use of indomethacin.

scholarly journals Anti-inflammatory effects of different statins in rheumatoid arthritis; a randomized double-blind controlled clinical trial

2019 ◽  
Vol 5 (1) ◽  
pp. e09-e09 ◽  
Author(s):  
Mansoor Karimifar ◽  
Mansour Salesi ◽  
Rasoul Ghasemian ◽  
Mozhgan Karimifar ◽  
Ziba Farajzadegan ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Clinical Trial ◽  
Controlled Clinical Trial ◽  
Double Blind ◽  
Anti Inflammatory
Sign in / Sign up

Export Citation Format

Share Document